MRSN logo

Mersana Therapeutics (MRSN) Shareholders Equity

Annual Shareholders Equity

$36.90 M
-$55.15 M-59.91%

December 31, 2023


Summary


Performance

MRSN Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMRSNbalance sheetmetrics:

Quarterly Shareholders Equity

$1.05 M
-$7.38 M-87.55%

September 30, 2024


Summary


Performance

MRSN Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMRSNbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

MRSN Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-59.9%-98.0%
3 y3 years-83.8%-98.0%
5 y5 years+319.6%-98.0%

MRSN Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-69.7%at low-99.3%at low
5 y5-year-83.8%at low-99.6%at low
alltimeall time-83.8%+166.3%-99.6%+101.5%

Mersana Therapeutics Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
$1.05 M(-87.6%)
Jun 2024
-
$8.43 M(-69.9%)
Mar 2024
-
$27.98 M(-24.2%)
Dec 2023
$36.90 M(-59.9%)
$36.90 M(-29.3%)
Sep 2023
-
$52.20 M(-41.9%)
Jun 2023
-
$89.80 M(+39.7%)
Mar 2023
-
$64.29 M(-30.2%)
Dec 2022
$92.06 M(-24.4%)
$92.06 M(+2.0%)
Sep 2022
-
$90.23 M(-32.7%)
Jun 2022
-
$134.03 M(-4.6%)
Mar 2022
-
$140.53 M(+15.4%)
Dec 2021
$121.74 M(-46.6%)
$121.74 M(-21.7%)
Sep 2021
-
$155.55 M(-20.4%)
Jun 2021
-
$195.51 M(-1.2%)
Mar 2021
-
$197.94 M(-13.2%)
Dec 2020
$228.09 M
$228.09 M(-10.0%)
DateAnnualQuarterly
Sep 2020
-
$253.31 M(-7.4%)
Jun 2020
-
$273.56 M(+333.6%)
Mar 2020
-
$63.09 M(-19.4%)
Dec 2019
$78.32 M(+790.5%)
$78.32 M(-15.8%)
Sep 2019
-
$93.05 M(-14.3%)
Jun 2019
-
$108.51 M(-12.5%)
Mar 2019
-
$124.07 M(+1310.7%)
Dec 2018
$8.79 M(-87.4%)
$8.79 M(-70.5%)
Sep 2018
-
$29.85 M(-34.7%)
Jun 2018
-
$45.69 M(-19.2%)
Mar 2018
-
$56.55 M(-19.2%)
Dec 2017
$69.99 M(-225.8%)
$69.99 M(-16.3%)
Sep 2017
-
$83.64 M(-216.7%)
Jun 2017
-
-$71.66 M(-330.1%)
Mar 2017
-
$31.14 M(-156.0%)
Dec 2016
-$55.62 M(+30.3%)
-$55.62 M
Dec 2015
-$42.69 M
-

FAQ

  • What is Mersana Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for Mersana Therapeutics?
  • What is Mersana Therapeutics annual shareholders equity year-on-year change?
  • What is Mersana Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Mersana Therapeutics?
  • What is Mersana Therapeutics quarterly shareholders equity year-on-year change?

What is Mersana Therapeutics annual stockholders equity?

The current annual shareholders equity of MRSN is $36.90 M

What is the all time high annual shareholders equity for Mersana Therapeutics?

Mersana Therapeutics all-time high annual stockholders equity is $228.09 M

What is Mersana Therapeutics annual shareholders equity year-on-year change?

Over the past year, MRSN annual stockholders equity has changed by -$55.15 M (-59.91%)

What is Mersana Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of MRSN is $1.05 M

What is the all time high quarterly shareholders equity for Mersana Therapeutics?

Mersana Therapeutics all-time high quarterly stockholders equity is $273.56 M

What is Mersana Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, MRSN quarterly stockholders equity has changed by -$51.15 M (-97.99%)